Regional and cell-specific expression of GDNF in rat brain.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Experimental Neurology

• Publication date

  1993-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/EXNR.1993.1207PMID 8287932
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential actions of neurotrophins in the locus coeruleus and basal forebrain.

  1993cited by this paper
• GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons.

  1993cited by this paper
• Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures.

  1993cited by this paper
• The neurotrophic factor concept: a reexamination

  1993cited by this paper
• Brain‐derived neurotrophic factor selectively rescues mesencephalic dopaminergic neurons from 2,4,5‐trihydroxyphenylalanine‐induced injury

  1993cited by this paper
• The nature of the trophic action of brain-derived neurotrophic factor, des(1-3)-insulin-like growth factor-1, and basic fibroblast growth factor on mesencephalic dopaminergic neurons developing in culture.

  1993cited by this paper
• Cortical astrocytes activated by basic fibroblast growth factor secrete molecules that stimulate differentiation of mesencephalic dopaminergic neurons

  1992cited by this paper
• Protection from 1-methyl-4-phenylpyridinium (MPP+) toxicity and stimulation of regrowth of MPP(+)-damaged dopaminergic fibers by treatment of mesencephalic cultures with EGF and basic FGF.

  1992cited by this paper
• Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture.

  1992cited by this paper
• Brain‐Derived Neurotrophic Factor Protects Dopamine Neurons Against 6‐Hydroxydopamine and N‐Methyl‐4‐Phenylpyridinium Ion Toxicity: Involvement of the Glutathione System

  1992cited by this paper
• Local support cells promote survival of substantia nigra dopaminergic neurons in culture.

  1991cited by this paper
• EGF enhances the survival of dopamine neurons in rat embryonic mesencephalon primary cell culture

  1991cited by this paper
• The neurotrophic effects of fibroblast growth factors on dopaminergic neurons in vitro are mediated by mesencephalic glia [published erratum appears in J Neurosci 1992 Mar;12(3):685]

  1991cited by this paper
• Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal cholinergic neurons in culture.

  1990cited by this paper
• Expression of NGF and NGF receptor mRNAs in the developing brain: evidence for local delivery and action of NGF.

  1989cited by this paper
• Basic fibroblast growth factor promotes the survival and development of mesencephalic neurons in culture.

  1989cited by this paper
• Rat mesencephalic neurons in culture exhibit different morphological traits in the presence of media conditioned on mesencephalic or striatal astroglia.

  1988cited by this paper
• The brain fibroblast growth factor (FGF) is localized in neurons.

  1986cited by this paper
• Brain-derived neurotrophic factor supports the survival of cultured rat retinal ganglion cells

  1986cited by this paper
• Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.

  1986cited by this paper
• Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture.

  1986cited by this paper
• A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and alzheimer disease

  1981cited by this paper
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

  1981cited by this paper
• DNA sequencing with chain-terminating inhibitors.

  1977cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Dopamine (3-hydroxytyramine) and brain function.

  1966cited by this paper

• Deregulation of Neuroinflammatory and Neurotrophic Factors as Biological Events Triggered by D-Galactose Chronic Administration in Wistar Rats

  2025cites this paper
• Gene Therapy for Parkinson’s Disease Using Midbrain Developmental Genes to Regulate Dopaminergic Neuronal Maintenance

  2024cites this paper
• Astrocyte-derived apolipoprotein D is required for neuronal survival in Parkinson’s disease

  2024cites this paper
• Finding an Optimal Level of GDNF Overexpression: Insights from Dopamine Cycling

  2023cites this paper
• LAR Downregulation Protects the Astrocytic U251 and Cocultured SH-SY5Y Cells in a Rotenone-Induced Parkinson’s Disease Cell Model

  2023cites this paper
• Cell–Cell Communication Alterations via Intercellular Signaling Pathways in Substantia Nigra of Parkinson’s Disease

  2022cites this paper
• The promise of the TGF-β superfamily as a therapeutic target for Parkinson's disease.

  2022cites this paper
• Power Failure of Mitochondria and Oxidative Stress in Neurodegeneration and Its Computational Models

  2021cites this paper
• Serum glial cell derived neurotrophic factor (GDNF) as a predictor of response to HD-tDCS in bipolar affective disorder.

  2021cites this paper
• GDNF/RET signaling in dopamine neurons in vivo

  2020cites this paper
• Gene Expression of Tyrosine Hydroxylase and Glutamate Receptors GluR1 and NR1 in Striatal Neurons of Parkinsonian Rats and Modulatory Effect of Bacoside-A, A Principle Constituent of Bacopa Monniera Linn

  2020cites this paper
• Interneuronas estriatales productoras de GDNF: características moleculares y rol en la neuroprotección catecolaminérgica

  2019cites this paper
• Ibogaine Modifies GDNF, BDNF and NGF Expression in Brain Regions Involved in Mesocorticolimbic and Nigral Dopaminergic Circuits

  2018cites this paper
• Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression

  2018cites this paper
• Astrocytes, Microglia, and Parkinson's Disease

  2018cites this paper
• Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis

  2018cites this paper
• A preliminary evaluation of glial cell line‐derived neurotrophic factor (GDNF) levels in cerebrospinal fluid across various gestational ages and clinical conditions of the neonate

  2018cites this paper
• The Role of Astrocyte Dysfunction in Parkinson’s Disease Pathogenesis

  2017cites this paper
• GLIAL CELL LINE-DERIVED NEUROTROPHC FACTOR RECEPTOR POLYPEPTIDES

  2017cites this paper
• Immune microenvironment of gliomas

  2017cites this paper
• Deconstructing the Iboga Alkaloid Skeleton: Potentiation of FGF2-induced Glial Cell Line-Derived Neurotrophic Factor Release by a Novel Compound.

  2016cites this paper
• A Muscle Perspective on the Pathophysiology of Amyotrophic Lateral Sclerosis : Differences between extraocular and limb muscles

  2016cites this paper
• Therapeutic Effects of Mesenchymal Stem Cells for Parkinson ’ s Disease

  2016cites this paper
• Astrocytes, therapeutic targets for neuroprotection and neurorestoration in ischemic stroke.

  2016influential citation
• Astrocytes show reduced support of motor neurons with aging that is accelerated in a rodent model of ALS.

  2015cites this paper
• Astrocyte physiopathology: At the crossroads of intercellular networking, inflammation and cell death.

  2015cites this paper
• From Man to Mouse: The MPTP Model of Parkinson Disease

  2015cites this paper
• GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson’s disease

  2015cites this paper
• Chronic inhibitory effect of riluzole on trophic factor production.

  2015cites this paper
• GDNF–Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease

  2015cites this paper
• La vitamina D regula la expresión del factor neurotrófico GDNF en cultivos neuronales estriatales y en ratas normales y hemiparkinsonianas

  2014cites this paper
• Beneficial effects of gfap/vimentin reactive astrocytes for axonal remodeling and motor behavioral recovery in mice after stroke

  2014cites this paper
• Amyotrophic Lateral Sclerosis: mechanism behind mutant SOD toxicity and improving current therapeutic strategies

  2014cites this paper
• Enhanced electrical responsiveness in the cerebral cortex with oral melatonin administration after a small hemorrhage near the internal capsule in rats

  2014cites this paper
• Glial modulators as potential treatments of psychostimulant abuse.

  2014cites this paper
• Factor neurotrófico derivado de la glía: una promesa terapéutica para la enfermedad de Parkinson

  2014cites this paper
• Comparison of GDF5 and GDNF as neuroprotective factors for postnatal dopamine neurons in ventral mesencephalic cultures

  2014cites this paper
• Emerging roles for glial pathology in addiction

  2014cites this paper
• GDNF is important for striatal organization and maintenance of dopamine neurons grown in the presence of the striatum.

  2014influential citation
• Dopamine D2 receptor activation leads to an up‐regulation of glial cell line–derived neurotrophic factor via Gβγ‐Erk1/2‐dependent induction of Zif268

  2013cites this paper
• RESTORATION OF MOTOR AND NON-MOTOR FUNCTIONS BY NEUROTROPHIC FACTORS IN NONHUMAN PRIMATES WITH DOPAMINE DEPLETION

  2013cites this paper
• Mesenchymal stem cells and neuroregeneration in Parkinson's disease.

  2013cites this paper
• Investigational surgical therapies

  2013cites this paper
• Dysfunction in the nigrostriatal system : effects of L-DOPA and GDNF

  2013cites this paper
• Regulation of neurotrophic factors and energy metabolism by antidepressants in astrocytes.

  2013cites this paper
• Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke.

  2013cites this paper
• Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factor.

  2012cites this paper
• Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy.

  2012cites this paper
• Gene Therapy for the Treatment of Parkinson’s Disease: The Nature of the Biologics Expands the Future Indications

  2012cites this paper
• Survival, differentiation, and connectivity of ventral mesencephalic dopamine neurons following transplantation.

  2012cites this paper
• Molecular Mechanisms Underlying Effects of Neural Stem Cells against Traumatic Axonal Injury

  2012cites this paper
• Prenatal LPS increases Inflammation in the Substantia Nigra of Gdnf Heterozygous Mice

  2011cites this paper
• Bidirectional axonal plasticity during reorganization of adult rat primary somatosensory cortex.

  2011cites this paper
• Regulation of Alzheimer’s disease-relevant protein processing in human neurons of the LUHMES cell line

  2011cites this paper
• Combination strategies for repair, plasticity, and regeneration using regulation of gene expression during the chronic phase after spinal cord injury

  2011cites this paper
• A cytokine mixture of GM-CSF and IL-3 that induces a neuroprotective phenotype of microglia leading to amelioration of (6-OHDA)-induced Parkinsonism of rats

  2011cites this paper
• Development of an In Vitro Model to Evaluate the Regenerative Capacity of Adult Brain-Derived Tyrosine Hydroxylase-Expressing Dopaminergic Neurons

  2011cites this paper
• A Novel Xenogeneic Co-Culture System to Examine Neuronal Differentiation Capability of Various Adult Human Stem Cells

  2011cites this paper
• Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.

  2011cites this paper
• 13.12 – Glial Cells*

  2010cites this paper
• Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential.

  2010cites this paper
• Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors

  2010cites this paper
• Neurotrophic factors modulation by adenosine receptors and dopamine release in the rat striatum

  2009cites this paper
• GDNF--a potential target to treat addiction.

  2009cites this paper
• Neurotrophic factors in neurodegenerative disorders: Model of parkinson’s disease

  2009cites this paper
• Death pathways activated in the neurotrophic factor-deprived neurons

  2009cites this paper
• Role of Ret Signaling in the Regulation of the Nigrostriatal Dopaminergic System in Mice

  2009cites this paper
• GDNF is an endogenous negative regulator of ethanol-mediated reward and of ethanol consumption after a period of abstinence.

  2009cites this paper
• Activation of group I metabotropic glutamate receptors leads to brain-derived neurotrophic factor expression in rat C6 cells.

  2009cites this paper
• Structure-Function Studies of GDNF Family Ligand-RET signalling

  2009cites this paper
• Facteur neurotrophique manf et ses utilisations

  2009cites this paper
• Intrastriatal grafts of mesenchymal stem cells in adult intact rats can elevate tyrosine hydroxylase expression and dopamine levels

  2009cites this paper
• NOVEL CDNF/MANF PROTEIN FAMILY: MOLECULAR STRUCTURE, EXPRESSION AND NEUROTROPHIC ACTIVITY

  2009cites this paper
• Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson’s disease

  2008cites this paper
• Astrocytes enhance long‐term survival of cholinergic neurons differentiated from human fetal neural stem cells

  2008cites this paper
• MANF is widely expressed in mammalian tissues and differently regulated after ischemic and epileptic insults in rodent brain.

  2008cites this paper
• Driving GDNF expression: the green and the red traffic lights.

  2008cites this paper
• Effects of glial cell line-derived neurotrophic factor (GDNF) on mouse fetal ventral mesencephalic tissue

  2008cites this paper
• Changes in Glial Cell Line-derived Neurotrophic Factor Expression in the Rostral and Caudal Stumps of the Transected Adult Rat Spinal Cord

  2008cites this paper
• On dopamine neurons : nerve fiber outgrowth and L-DOPA effects

  2008cites this paper
• Frontiers in the surgical treatment of Parkinson’s disease

  2008cites this paper
• AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neurons.

  2008cites this paper
• Expression of GDNF transgene in astrocytes improves cognitive deficits in aged rats.

  2008cites this paper
• Activation of microglia by endotoxin suppresses the secretion of glial cell line–derived neurotrophic factor (GDNF) through the action of protein kinase Cα (PKCα) and mitogen‐activated protein kinases (MAPKS)

  2008cites this paper
• Dopamine receptor agonists for protection and repair in Parkinson's disease.

  2008cites this paper
• Proteome Analysis of Serum-Containing Conditioned Medium from Primary Astrocyte Cultures

  2008cites this paper
• Role of heparin binding growth factors in nigrostriatal dopamine system development and Parkinson's disease.

  2007cites this paper
• Neuroinflammation and Parkinson's disease.

  2007cites this paper
• Differential effects of glial cell line-derived neurotrophic factor on A9 and A10 dopamine neuron survival in vitro.

  2007cites this paper
• Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures.

  2007cites this paper
• AAV-vector mediated gene delivery for Huntington's Disease : an investigative therapeutic study.

  2007cites this paper
• Distribution and immunohistochemical localization of GDNF protein in selected neural and non-neural tissues of rats during development and changes in unilateral 6-hydroxydopamine lesions.

  2007cites this paper
• Tissue distribution of Ret, GFRalpha-1, GFRalpha-2 and GFRalpha-3 receptors in the human brainstem at fetal, neonatal and adult age.

  2007cites this paper
• Neurotrophic factor regulation of gene expression in primary sensory neurons of the mouse

  2007cites this paper
• Overexpression of pitx3 upregulates expression of BDNF and GDNF in SH‐SY5Y cells and primary ventral mesencephalic cultures

  2007cites this paper
• Increased cell suspension concentration augments the survival rate of grafted tyrosine hydroxylase immunoreactive neurons.

  2007cites this paper
• An Immortalized Rat Ventral Mesencephalic Cell Line, RTC4, Is Protective in a Rodent Model of Stroke

  2007cites this paper
• Changes in Glial Cell Line-derived Neurotrophic Factor Expression in the Rostral and Caudal Stumps of the Transected Adult Rat Spinal Cord

  2007cites this paper
• Specific regulation of rat glial cell line‐derived neurotrophic factor gene expression by riluzole in C6 glioma cells

  2006cites this paper
• In vivo gene therapy as a potential treatment for Parkinson's disease

  2006cites this paper